Funding Details
- Awarder
- Inbox
- Date Award
- June 25, 2024
- Vertical
- Genomic Medicines
- Funding URL
- View Funding Page
- Funding Amount:
-
$82,000,000
Company Info
- Founders
- Tal Zaks, M.D., Ph.D.
- Company Description
- Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
- Market
- Genetic Diseases, Cancer, Autoimmune Conditions
- Location
-
New York,
NY,
USA
- Coinvestors
- Arc Ventures, Deep Insight, Delos Capital, Innovation Endeavors, Insight Partners, Invus, Novartis Venture Funds, OrbiMed US
Links